Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GCGR | P47871 | 1/20 | 0.31 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.31 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12539081 | 0.89 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 | |
| SCHEMBL13531374 | 0.89 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 | |
| SCHEMBL15440689 | 0.80 | NOS2 (0.35) | ALDH1A1PKMHPGDKCNH2MEN1 | |
| SCHEMBL1187671 | 0.77 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 | |
| SCHEMBL1187550 | 0.77 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 | |
| SCHEMBL1189782 | 0.77 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 | |
| SCHEMBL1187257 | 0.77 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 | |
| SCHEMBL1187685 | 0.77 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 | |
| SCHEMBL1187133 | 0.77 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 | |
| SCHEMBL1187104 | 0.77 | ALDH1A1 (0.42) | DHFRALDH1A1PKMHPGDKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110127467-A1 | COMPOSITION COMPRISING PHOSPHORESCENT COMPOUND AND LIGHT EMITTING DEVICE USING THE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2308926-A1 | COMPOSITION COMPRISING PHOSPHORESCENCE EMITTING COMPOUND, AND LIGHT EMITTING ELEMENT USING THE COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2011-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110127467-A1 | COMPOSITION COMPRISING PHOSPHORESCENT COMPOUND AND LIGHT EMITTING DEVICE USING THE COMPOSITION | CCNE2, CDCA2, CCNA2 | DHFR 2569/4885ALDH1A1 4320/4885PKM 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.